High Risk HLA-A2+ Melanoma
1 clinical trials · Condition
◉ Watch High Risk HLA-A2+ Melanoma
| Record | Firm | Date |
|---|---|---|
| Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients (NCT01861938) | Hadassah Medical Organization | 2017-03-01 |
Track High Risk HLA-A2+ Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.